Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
YOTAW
13726
DELISTED
Yotta Acquisition Corporation Warrant
YOTAW
| $7.01K | ﹤0.01% |
120,854
+8,273
| +7% | +$401 |
2024 Q3
1 quarter
|
|
13727
PUT
Destination XL Group
DXLG
$22.1M
| $6.99K | ﹤0.01% |
+2,600
| New | +$6.98K |
2024 Q4
0 quarters
|
|
|
KW
13728
PUT
DELISTED
Kennedy-Wilson Holdings
KW
| $6.99K | ﹤0.01% |
700
-400
| -36% | -$4.37K |
2022 Q4
8 quarters
|
|
13729
CALL
Biomerica
BMRA
$9.43M
| $6.99K | ﹤0.01% |
2,913
-3,800
| -57% | -$10K |
2024 Q3
1 quarter
|
|
13730
CALL
Orthofix Medical
OFIX
$387M
| $6.98K | ﹤0.01% |
400
+100
| +33% | +$1.74K |
2024 Q1
3 quarters
|
|
|
13731
PUT
Orthofix Medical
OFIX
$387M
| $6.98K | ﹤0.01% |
400
+300
| +300% | +$5.22K |
2024 Q1
3 quarters
|
|
13732
Ovid Therapeutics
OVID
$457M
| $6.96K | ﹤0.01% |
+7,457
| New | +$8.34K |
2024 Q4
0 quarters
|
|
13733
PUT
OrthoPediatrics
KIDS
$598M
| $6.95K | ﹤0.01% |
300
| – | – |
2022 Q3
9 quarters
|
|
13734
CALL
Seer Inc
SEER
$129M
| $6.93K | ﹤0.01% |
+3,000
| New | +$6.58K |
2024 Q4
0 quarters
|
|
13735
PUT
Lakeland Financial Corp
LKFN
$1.45B
| $6.88K | ﹤0.01% |
100
| – | – |
2024 Q1
3 quarters
|
|
13736
Sprinklr
CXM
$1.21B
| $6.84K | ﹤0.01% |
809
-91,296
| -99% | -$730K |
2024 Q3
1 quarter
|
|
|
ARDT
13737
PUT
Ardent Health
ARDT
$1.49B
| $6.83K | ﹤0.01% |
400
| – | – |
2024 Q3
1 quarter
|
|
13738
CALL
Towne Bank
TOWN
$3.31B
| $6.81K | ﹤0.01% |
200
-1,100
| -85% | -$38.3K |
2022 Q4
8 quarters
|
|
|
VACHW
13739
DELISTED
Voyager Acquisition Corp Warrants
VACHW
| $6.79K | ﹤0.01% |
+54,346
| New | +$5K |
2024 Q4
0 quarters
|
|
|
BRSP
13740
PUT
BrightSpire Capital
BRSP
$477M
| $6.77K | ﹤0.01% |
1,200
+200
| +20% | +$1.18K |
2022 Q4
8 quarters
|
|
13741
PUT
Enliven Therapeutics
ELVN
$3.33B
| $6.75K | ﹤0.01% |
300
-200
| -40% | -$5.18K |
2024 Q2
2 quarters
|
|
|
CNTA
13742
PUT
DELISTED
Centessa Pharmaceuticals
CNTA
| $6.7K | ﹤0.01% |
400
-29,100
| -99% | -$482K |
2023 Q2
6 quarters
|
|
|
PARAA
13743
CALL
DELISTED
Paramount Global Class A
PARAA
| $6.69K | ﹤0.01% |
300
-5,800
| -95% | -$129K |
2024 Q1
3 quarters
|
|
13744
PUT
Avantis US Large Cap Value ETF
AVLV
$21.7B
| $6.68K | ﹤0.01% |
+100
| New | +$6.8K |
2024 Q4
0 quarters
|
|
13745
CALL
Sportsman's Warehouse
SPWH
$45.4M
| $6.67K | ﹤0.01% |
2,500
-19,700
| -89% | -$49.3K |
2021 Q4
12 quarters
|
|
|
SBFMW
13746
Sunshine Biopharma Inc Warrant
SBFMW
$77.2K
| $6.67K | ﹤0.01% |
41,431
-3,700
| -8% | -$574 |
2023 Q2
6 quarters
|
|
13747
PUT
RAVE Restaurant Group
RAVE
$32.5M
| $6.66K | ﹤0.01% |
2,600
+800
| +44% | +$2.24K |
2024 Q2
2 quarters
|
|
13748
PUT
Kemper
KMPR
$1.52B
| $6.64K | ﹤0.01% |
100
-100
| -50% | -$6.6K |
2022 Q4
8 quarters
|
|
13749
PUT
ALPS Medical Breakthroughs ETF
SBIO
$204M
| $6.61K | ﹤0.01% |
+200
| New | +$7.55K |
2024 Q4
0 quarters
|
|
13750
PUT
Commerce Bancshares
CBSH
$7.91B
| $6.54K | ﹤0.01% |
110
-111
| -50% | -$6.69K |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.